Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 197.85 million compared to CNY 133.75 million a year ago. Revenue was CNY 197.85 million compared to CNY 133.75 million a year ago. Net income was CNY 40.73 million compared to CNY 17.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.2286 compared to CNY 0.1286 a year ago. Diluted earnings per share from continuing operations was CNY 0.2286 compared to CNY 0.1286 a year ago.